PmrAB, a two-component regulatory system of Pseudomonas aeruginosa that modulates resistance to cationic antimicrobial peptides and addition of aminoarabinose to lipid A

被引:307
作者
Moskowitz, SM
Ernst, RK
Miller, SI
机构
[1] Univ Washington, Sch Med, Dept Med, Seattle, WA 98195 USA
[2] Univ Washington, Sch Med, Dept Microbiol, Seattle, WA 98195 USA
[3] Univ Washington, Sch Med, Dept Genome Sci, Seattle, WA 98195 USA
关键词
D O I
10.1128/JB.186.2.575-579.2004
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
Spontaneous polymyxin-resistant mutants of Pseudomonas aeruginosa were isolated. The mutations responsible for this phenotype were mapped to a two-component signal transduction system similar to PmrAB of Salmonella enterica serovar Typhimurium. Lipid A of these mutants contained aminoarabinose, an inducible modification that is associated with polymyxin resistance. Thus, P. aeruginosa possesses a mechanism that induces resistance to cationic antimicrobial peptides in response to environmental conditions.
引用
收藏
页码:575 / 579
页数:5
相关论文
共 42 条
  • [1] BASIC LOCAL ALIGNMENT SEARCH TOOL
    ALTSCHUL, SF
    GISH, W
    MILLER, W
    MYERS, EW
    LIPMAN, DJ
    [J]. JOURNAL OF MOLECULAR BIOLOGY, 1990, 215 (03) : 403 - 410
  • [2] CHARACTERIZATION OF ESCHERICHIA-COLI GLNL MUTATIONS AFFECTING NITROGEN REGULATION
    ATKINSON, MR
    NINFA, AJ
    [J]. JOURNAL OF BACTERIOLOGY, 1992, 174 (14) : 4538 - 4548
  • [3] Regulation of Salmonella typhimurium virulence gene expression by cationic antimicrobial peptides
    Bader, MW
    Navarre, WW
    Shiau, W
    Nikaido, H
    Frye, JG
    McClelland, M
    Fang, FC
    Miller, SI
    [J]. MOLECULAR MICROBIOLOGY, 2003, 50 (01) : 219 - 230
  • [4] The peptide antibiotic LL-37/hCAP-18 is expressed in epithelia of the human lung where it has broad antimicrobial activity at the airway surface
    Bals, R
    Wang, XR
    Zasloff, M
    Wilson, JM
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1998, 95 (16) : 9541 - 9546
  • [5] Human β-defensin 2 is a salt-sensitive peptide antibiotic expressed in human lung
    Bals, R
    Wang, XR
    Wu, ZR
    Freeman, T
    Bafna, V
    Zasloff, M
    Wilson, JM
    [J]. JOURNAL OF CLINICAL INVESTIGATION, 1998, 102 (05) : 874 - 880
  • [6] STRUCTURAL STUDIES OF LIPID-A FROM PSEUDOMONAS-AERUGINOSA PAO1 - OCCURRENCE OF 4-AMINO-4-DEOXYARABINOSE
    BHAT, R
    MARX, A
    GALANOS, C
    CONRAD, RS
    [J]. JOURNAL OF BACTERIOLOGY, 1990, 172 (12) : 6631 - 6636
  • [7] ROLE OF DIVALENT CATIONS IN ACTION OF POLYMYXIN-B AND EDTA ON PSEUDOMONAS-AERUGINOSA
    BROWN, MRW
    MELLING, J
    [J]. JOURNAL OF GENERAL MICROBIOLOGY, 1969, 59 : 263 - &
  • [8] Longitudinal assessment of Pseudomonas aeruginosa in young children with cystic fibrosis
    Burns, JL
    Gibson, RL
    McNamara, S
    Yim, D
    Emerson, J
    Rosenfeld, M
    Hiatt, P
    McCcoy, K
    Castile, R
    Smith, AL
    Ramsey, BW
    [J]. JOURNAL OF INFECTIOUS DISEASES, 2001, 183 (03) : 444 - 452
  • [9] FATTY-ACID ALTERATIONS AND POLYMYXIN-B BINDING BY LIPOPOLYSACCHARIDES FROM PSEUDOMONAS-AERUGINOSA ADAPTED TO POLYMYXIN-B RESISTANCE
    CONRAD, RS
    GALANOS, C
    [J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1989, 33 (10) : 1724 - 1728
  • [10] Conway SP, 2000, ANN PHARMACOTHER, V34, P1238